Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Integra LifeSciences Holdings Corp

+ Add to Watchlist

IART:US

64.6200 USD 0.2600 0.40%

As of 17:20:00 ET on 05/06/2015.

Snapshot for Integra LifeSciences Holdings Corp (IART)

Open: 65.0000 Day's Range: 64.4600 - 65.5200 Volume: 330,041
Previous Close: 64.8800 52wk Range: 43.5537 - 66.7300 1-Yr Rtn: +46.86%

Stock Chart for IART

No chart data available.
  • IART:US 64.6200
  • 1D
  • 1M
  • 1Y
64.8800
Interactive IART Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IART

Current P/E Ratio (ttm) 28.0584
Estimated P/E(12/2015) 20.0746
Relative P/E vs. SPX 1.5273
Earnings Per Share (USD) (ttm) 2.3023
Est. EPS (USD) (12/2015) 3.2180
Est. PEG Ratio 1.5720
Market Cap (M USD) 2,127.56
Shares Outstanding (M) 32.93
30 Day Average Volume 184,364
Price/Book (mrq) 3.0852
Price/Sale (ttm) 2.2311
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IART

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IART

Integra LifeSciences Holdings develops, manufactures, and markets medical devices, implants, and biomaterials. The Company's products are primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics, and other surgical applications.

Peter J ArduiniPresident/CEOGlenn G ColemanVP/CFO
Kenneth Burhop "Ken"VP/Chief Scientific OfcrPadma ThiruvengadamVP/Chief Human Resources Ofcr
More Company Profile & Key Executives for IART

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil